Florida Surgeon General Joseph Ladapo has recommended a pause in the use of mRNA COVID-19 vaccines, expressing serious concerns about the potential for DNA integration. [Source]
Ladapo’s concerns center on the possibility that DNA fragments present in mRNA vaccines could integrate with human DNA, posing risks such as cancer development. This issue of DNA integration, he argues, has not been adequately assessed by the U.S. Food and Drug Administration (FDA), a lapse that warrants immediate attention.
“DNA integration poses a unique and elevated risk to human health and to the integrity of the human genome,” Ladapo stated, pointing out the potential for these effects to be passed onto the offspring of vaccine recipients.
This stance comes after Ladapo’s queries to the Center for Biologics Evaluation and Research, where Dr. Peter Marks suggested the likelihood of such DNA integration was unlikely. However, Ladapo found this response unsatisfactory, criticizing the FDA for not providing data or evidence that the recommended DNA integration assessments have been performed. [Source]
Ladapo’s call for caution reflects a deeper concern about the FDA and the Centers for Disease Control and Prevention’s (CDC) approach to COVID-19 vaccine safety. “The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have always played it fast and loose with COVID-19 vaccine safety,” Ladapo noted, underscoring the need for thorough testing, especially when vaccines are known to contain foreign DNA.
This move by Florida’s top health official stresses the importance of adhering to strict safety protocols and guidelines in public health interventions, especially when dealing with new and rapidly developed medical technologies like mRNA vaccines. It also reflects a growing need for transparency and accountability from regulatory agencies in their vaccine evaluation processes.
Ladapo’s recommendation, while controversial, aligns with a cautious approach to healthcare, prioritizing the long-term well-being of individuals.